Skip to main content
. 2016 Apr 13;7(21):30323–30335. doi: 10.18632/oncotarget.8730

Table 1. Data Collection and Refinement Statistics (Molecular Replacement).

PD-L1 in complex with the small-molecule inhibitor (BMS-202) PD-L1 in complex with the small-molecule inhibitor (BMS-8)
Data collection
Space group P 21 21 21 P 2 21 21
Cell dimensions
a, b, c (Å) 40.83, 85.09, 161.77 34.31, 55.18, 141.77
 α, β, γ (°) 90, 90, 90 90, 90, 90
Resolution (Å) 42.55 - 2.2 (2.279 - 2.2)* 47.26 - 2.3 (2.38 - 2.3)*
Rmerge 0.05 (0.272)* 0.093 (0.465)*
I / σI 23 (6.3)* 12.4 (3.6)*
Completeness (%) 99.3 (99.0)* 99.9 (100.0)*
Redundancy 3.4 (3.5)* 6.8 (7.4)*
Refinement
Resolution (Å) 2.2 2.3
No. reflections 29405 (2879) 12626 (1191)
Rwork / Rfree 0.2064 / 0.2582 (0.2666/0.3452) 0.2390 / 0.2970 (0.2691/0.3845)
No. atoms 4122 1968
 Protein 3848 1906
 Ligand/ion 66 32
 Water 208 30
B-factors 48.27 45.15
 Protein 48.61 45.17
 Ligand/ion 47.08 42.77
 Water 42.31 46.53
R.m.s. deviations
 Bond lengths (Å) 0.009 0.014
 Bond angles (°) 1.005 1.85
*

Values in parentheses are for highest-resolution shell.

HHS Vulnerability Disclosure